SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

被引：0
|
作者：
C. Kratochwil
M. Stefanova
E. Mavriopoulou
T. Holland-Letz
A. Dimitrakopoulou-Strauss
A. Afshar-Oromieh
W. Mier
U. Haberkorn
F. L. Giesel
机构：
[1] University Hospital Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Biostatistics
[3] German Cancer Research Center,KKE Nuclear Medicine
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Neuroendocrine tumors; Peptide-related radionuclide therapy; [; Ga]DOTATOC; Somatostatin receptor; SUV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 318
页数：5
相关论文
共 50 条
  • [41] Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)
    Vega-Zolano, Elizabeth
    Ruiz, Erika
    Caderillo-Ruiz, German
    Diaz, Consuelo
    Herrera, Marytere
    Torres Agredo, Liliana Patricia
    Soldevilla-Gallardo, Irma
    Michel-Sanchez, Emiliano
    Garcia-Perez, Francisco Osvaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
    Muessig, K.
    Oeksuez, M.
    Dudziak, K.
    Ueberberg, B.
    Wehrmann, M.
    Horger, M.
    Schulz, S.
    Pfannenberg, C.
    Gallwitz, B.
    Petersenn, S.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 47 - 47
  • [43] Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
    Muessig, K.
    Oeksuez, M. Oe.
    Dudziak, K.
    Ueberberg, B.
    Wehrmann, M.
    Horger, M.
    Schulz, S.
    Haering, H. U.
    Pfannenberg, C.
    Bares, R.
    Gallwitz, B.
    Petersenn, S.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (08) : 599 - 606
  • [44] [68Ga]Ga-DOTA-FAPI-04 PET/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC PET/CT missed
    Al-Ibraheem, Akram
    Alyasjeen, Salem Fandi
    Abdlkadir, Ahmed Saad
    Sheikha, Areej Abu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (13) : 4112 - 4113
  • [45] [68Ga]Ga-DOTA-FAPI-04 PET/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC PET/CT missed
    Akram Al-Ibraheem
    Salem Fandi Alyasjeen
    Ahmed Saad Abdlkadir
    Areej Abu Sheikha
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 4112 - 4113
  • [46] 68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
    Ruf, Juri
    Schiefer, Jan
    Furth, Christian
    Kosiek, Ortud
    Kropf, Siegfried
    Heuck, Friederike
    Denecke, Timm
    Pavel, Marianne
    Pascher, Andreas
    Wiedenmann, Bertram
    Amthauer, Holger
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (05) : 697 - 704
  • [47] Utility of 68Ga DOTA-Octreotate PET/CT in Characterization of Pediatric Neuroendocrine Tumors
    McKone, E. L.
    Kowalchuk, R. O.
    Dorr, M.
    Cameron, J. D.
    Connors, M. A.
    Allen-Rhoades, W.
    Schoettler, P. J.
    Rawwas, J.
    Johnson, D. R.
    Johnson, G. B.
    Mahajan, A.
    Ahmed, S. K.
    Laack, N. N., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E704 - E705
  • [48] 68Ga DOTA TATE PET/CT in patients with neuroendocrine tumors: a technologist's perspective
    Luan Nguyen
    Moradi, Farshad
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [49] Clinical impact of [68Ga] Ga-DOTA-TOC PET/CT in the management of neuroendocrine tumors.
    Palacios, J. Villa
    Luquin, T. Aroui
    Rivas-Navas, D.
    Guijarro-Caba, P.
    De Fuentes, M. Muros
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S511 - S511
  • [50] Factors affecting SUV measurement in 68Ga-DOTANOC PET/CT studies in neuroendocrine tumors
    Chotipanich, C.
    Przewloka, K.
    Israel, O.
    Frencel, A.
    Kennedy, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S281 - S282
12345